Real-Time Automated Batch Release in Life Sciences

This research spotlight presents an analysis of the challenges and considerations associated with implementing real-time automated batch release (RTR) in the life sciences sector. It outlines the historical context of RTR, including the FDA's guidance on Process Analytical Technology (PAT) and the principles of Quality by Design (QbD). The document details the advanced digital tools necessary for achieving automated RTR, such as AI/ML and Robotic Process Automation (RPA), and discusses the significant benefits, including reduced inventory levels and improved product quality. Several challenges to realizing RTR are identified, including manual technology transfer, regulatory constraints, and the need for comprehensive digital data availability. The spotlight emphasizes the importance of early engagement of quality functions in product development and the logistical challenges posed by the increasing reliance on Contract Design & Manufacturing Organizations (CDMOs). Overall, the document serves as a guide for life sciences companies exploring the feasibility and implications of adopting automated RTR processes.